Ein schneller und genauer diagnostischer Test zum Nachweis von Influenza und COVID-19 am Point-of-Care
In the post-pandemic era, it has become critical to distinguish between influenza and COVID-19 during flu season. However, due to the similar symptoms caused, it is actually challenging for clinicians to identify solely based on the signs and symptoms. Besides, the conventional time-consuming molecular tests might also provide the window period for virus spread. Hence, rapid and accurate testing which simultaneously detects influenza virus and SARS-CoV-2 has become essential to provide a timely diagnosis and help doctors make precise medical decisions on the spot.
VitaPCR™ Influenza/SARS-CoV-2 (Flu/SC2) Assay
REGISTRIERUNGSSTATUS
CE-marked (IVDD)
VitaPCR™ – Accurate diagnostics, whenever and wherever you need it.
Combining a simplified 1 minute hands-on time procedure to ensure seamless integration into practitioners’ workflow, a compact and reliable design without the need for extra equipment like refrigeration, and a proprietary RT-PCR technology allowing fast and accurate diagnostics; VitaPCR™ allows the detection of Influenza and SARS-CoV-2 in 20 minutes from sample to results, at the Point-of-Care.
VitaPCR™ empowers practitioners with the right information at the right time to make the right decision and provide the right course of treatment to the patients.
Benutzerfreundlichkeit
- Minimale Schulung erforderlich
- Keine zusätzliche Ausrüstung erforderlich
- Lagerung bei Raumtemperatur
Leistung
- High Accuracy
- Short Turnaround Time
- Intuitive Auswertung der Ergebnisse anhand des Ct-Werts und der Fluoreszenzkurve
Diagnostisches Verfahren in 4 Schritten

Sammeln Sie
Probe sammeln

Lyse
Spülen Sie die Probe
15 Mal gründlich durch.

Übertragung
Übertragen Sie die Probe

Startlauf
Ergebnisse unter
20 Minuten

Sammeln Sie
Probe sammeln

Lyse
Spülen Sie die Probe
15 Mal gründlich durch.

Übertragung
Übertragen Sie die Probe

Startlauf
Ergebnisse unter
20 Minuten
Intuitive Ergebnisinterpretation
VitaPCR™ Influenza/SARS-CoV-2 (Flu/SC2) Assay
Catalog No.
PCRAE0128
Technology
rRT-PCR
Menge
, 20 Tests/Packung
Targets
• M Gene – Influenza A
• NS Gene – Influenza B
• N Gene – SARS-CoV-2
Sample Types
Nasopharyngeal Swabs
Hands-on Time
< 1 min
Turnaround Time
20 mins
Lagerungs
n für das Kit: 5 – 25 °C / 41 – 77 °F